Author

Hardik Vasnawala

Observed names: H Vasnawala, H. Vasnawala, HARDIK VASNAWALA, Vasnawala Hardik

Observed institutions: AstraZeneca (United Kingdom), Medanta The Medicity, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, University of Leicester, Chellaram Hospital, Krishna Institute of Medical Sciences, Fortis Escorts Heart Institute, Life Care Institute of Medical Sciences & Research, Sri Ramachandra Medical Centre, Medanta The Medicity, Bangalore Diabetes Centre, AstraZeneca (India), Yashoda Hospital, Kokilaben Dhirubhai Ambani Hospital, St.John's Medical College Hospital, Bharti Hospital

OpenAlex ID: A5049963255

Pleiotropic effects of statins

2015 · Hardik Vasnawala, Narasaraju Kavalipati, et al. · Indian Journal of Endocrinology and Metabolism · 182

LIPITENSION : Interplay between dyslipidemia and hypertension

2012 · Ashish Gulati, JamshedJ Dalal, et al. · Indian Journal of Endocrinology and Metabolism · 143

Genital Infections with Sodium Glucose Cotransporter-2 Inhibitors: Occurrence and Management in Patients with Type 2 Diabetes Mellitus

2018 · A. G. Unnikrishnan, Sanjay Kalra, et al. · Indian Journal of Endocrinology and Metabolism · 99

Prevalence of dyslipidemia in adult Indian diabetic patients: A cross sectional study (SOLID)

2014 · Hardik Vasnawala, Ambrish Mithal, et al. · Indian Journal of Endocrinology and Metabolism · 49

An observational, cross-sectional study to assess the prevalence of chronic kidney disease in type 2 diabetes patients in India (START -India)

2015 · Hardik Vasnawala, M Prasannakumar, et al. · Indian Journal of Endocrinology and Metabolism · 48

Plaque regression and plaque stabilisation in cardiovascular diseases

2013 · Tarun Dave, J. Ezhilan, et al. · Indian Journal of Endocrinology and Metabolism · 39

A Study to derive distribution of carotid intima media thickness and to determine its COrrelation with cardiovascular Risk factors in asymptomatic nationwidE Indian population (SCORE-India)

2016 · Ravi R. Kasliwal, Manish Bansal, et al. · Indian Heart Journal · 33

PDF

Prevalence of Chronic Kidney Disease (CKD) in Type 2 Diabetes Mellitus Patients: START-India Study

2017 · Rajesh Rajput, K M Prasanna Kumar, et al. · Journal of Diabetes & Metabolism · 21

Prevalence of sympathetic overactivity in hypertensive patients – A pan India, non-interventional, cross sectional study

2014 · T.N.C. Padmanabhan, Sameer Dani, et al. · Indian Heart Journal · 12

PDF

Prevalence of cardiac abnormalities and heart failure in unselected out-patients with type 2 diabetes mellitus and associated clinical factors: Real-world evidence from an Indian registry

2023 · Rajesh Rajput, J.C. Mohan, et al. · Indian Heart Journal · 8

Global Validation of a Model to Predict Reduced Estimated GFR in People With Type 2 Diabetes Without Diagnosis of CKD

2024 · Camilla Sammut-Powell, Rose Sisk, et al. · Kidney International Reports · 1

Clinical Characteristics, Comorbidities, and Management of Patients with CKD: Insights from iCaReMe Global Registry

2023 · Carol A. Pollock, Kamlesh Khunti, et al. · Journal of the American Society of Nephrology · 1

#6054 Clinical Characteristics and Renal Risk of Patients With Chronic Kidney Disease: Real-world Evidence From the Icareme Global Registry

2023 · Mustafa Arici, Carol Pollock, et al. · Nephrology Dialysis Transplantation · 1

PDF

A Global Validation of a Minimal-Resource Pre-Screening Model for Reduced Kidney Function in Patients With Type 2 Diabetes

2022 · Rose Sisk, Camilla Sammut-Powell, et al. · Journal of the American Society of Nephrology · 1

Real-world implementation of guideline-directed medical therapy in heart failure across the ejection fraction spectrum: Insights from iCaReMe Global Registry

2026 · A Hadaoui, C Pollock, et al. · European Journal of Heart Failure

Uncontrolled Hypertension in Cardio‐Renal‐Metabolic Diseases: Real‐World Insights on Patient Profiles and Management Patterns From iCaReMe Global Registry

2026 · Kamlesh Khunti, Mustafa Arici, et al. · International Journal of Hypertension

PDF

Abstract 4365307: Burden of uncontrolled hypertension in real world practice: Insights from iCaReMe Global Registry

2025 · Kamlesh Khunti, Mustafa ARICI, et al. · Circulation

Abstract 4358809: Clinical characteristics and management of patients with hypertension and cardiovascular-renal-metabolic diseases in routine care: Insights from iCaReMe Global Registry

2025 · Kamlesh Khunti, Mustafa ARICI, et al. · Circulation

#2530 Hyperkalaemia prevalence and risk factors in chronic kidney disease and heart failure: insights from iCaReMe registry middle east and Africa cohort

2025 · Sola Aoun, Mustafa Arici, et al. · Nephrology Dialysis Transplantation

PDF

#2546 Hyperkalaemia prevalence and risk factors in chronic kidney disease and heart failure: insights from iCaReMe Registry Latin America Cohort

2025 · Magdalena Madero, Luiz Aparecido Bortolotto, et al. · Nephrology Dialysis Transplantation

Wcn25-2734 Clinical Characteristics and Treatment Patterns in Chronic Kidney Disease: Real-world Insights From Icareme Registry-jordan and Lebanon Cohort

2025 · Sola Aoun Bahous, Mohammad Ghnaimat, et al. · Kidney International Reports

IDF23-0298 Management of type 2 diabetes in heart failure: Insights from iCaReMe Global Registry

2024 · S. Joshi, C. Pollock, et al. · Diabetes Research and Clinical Practice

IDF23-0274 Management of type 2 diabetes in chronic kidney disease: Insights from iCaReMe Global Registry

2024 · S. Joshi, C. Pollock, et al. · Diabetes Research and Clinical Practice

Abstract 14017: Clinical Characteristics and Treatment Patterns in Patients With Heart Failure: Results From the Icareme Middle East and Africa Cohort

2023 · Bassem Zarif, Yuksel Cavusoglu, et al. · Circulation

Abstract 13644: Management Patterns in Patients With Heart Failure: Insights From iCaReMe Global Registry

2023 · Mikhail N Kosiborod, Carolyn S Lam, et al. · Circulation

Works count: 33

Citation count: 671

H-index: 10

I10-index: 10